Efficacy of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma
This study showed the potential efficacy of immunotherapy as a first-line treatment for PSC. While acknowledging the retrospective nature of the study, our findings suggest a trend favoring the combination of IO CT over IO alone in these patients.
Authors
- Jennifer Arrondeau
- Isabelle Monnet (ORCID: https://orcid.org/0000-0003-3279-9569)
- Isabelle Cremer (ORCID: https://orcid.org/0000-0002-0963-1031)
- Etienne Giroux‐Leprieur (ORCID: https://orcid.org/0000-0001-8441-1701)
- Elizabeth Fabre (ORCID: https://orcid.org/0000-0002-1244-873X)
- Gary Birsen (ORCID: https://orcid.org/0009-0007-3534-1007)
- Marie Wislez (ORCID: https://orcid.org/0000-0001-7518-7859)
- Marco Alifano
- V. Gounant (ORCID: https://orcid.org/0000-0002-9473-1247)
- Karen Leroy (ORCID: https://orcid.org/0000-0002-4379-0140)
- Diane Damotte (ORCID: https://orcid.org/0000-0001-5355-3045)
- Christine Raynaud-Donzel (ORCID: https://orcid.org/0000-0002-6658-3806)
- Nicolas M Girard (ORCID: https://orcid.org/0000-0001-9909-2299)
- Jeanne Chapron (ORCID: https://orcid.org/0009-0001-0178-5861)
- Jacques Cadranel (ORCID: https://orcid.org/0000-0003-2446-2923)
Institutions
- Inserm (FR)
- Délégation Paris 7 (FR)
- Université de Versailles Saint-Quentin-en-Yvelines (FR)
- Université Paris Cité (FR)
- Université Paris-Saclay (FR)
- Sorbonne Université (FR)
- Sorbonne Paris Cité (FR)
- Centre de Recherche des Cordeliers (FR)
- Hôpital Cochin (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Européen Georges-Pompidou (FR)
- Hôpital Ambroise-Paré (FR)
- Centre Hospitalier Victor Dupouy (FR)
- Hôpital Bichat-Claude-Bernard (FR)
- Hôpital Intercommunal de Créteil (FR)
- Hôpital Tenon (FR)
Publication Details
- Journal
- Translational Lung Cancer Research
- Published
- 2024-09-01
- DOI
- https://doi.org/10.21037/tlcr-24-263
- Citations
- 4
- Primary Topic
- Metastasis and carcinoma case studies
- Type
- article
- Field-Weighted Citation Impact
- 1.68
Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Gilead Sciences
- Regeneron Pharmaceuticals
- Merck KGaA
- BeiGene
- Daiichi-Sankyo
- Ipsen